171 related articles for article (PubMed ID: 6287139)
1. Assessment of alpha 2 adrenergic autoreceptor function in humans: effects of oral yohimbine.
Charney DS; Heninger GR; Sternberg DE
Life Sci; 1982 Jun; 30(23):2033-41. PubMed ID: 6287139
[TBL] [Abstract][Full Text] [Related]
2. alpha 2-Adrenergic receptor sensitivity in depression. The plasma MHPG, behavioral, and cardiovascular responses to yohimbine.
Heninger GR; Charney DS; Price LH
Arch Gen Psychiatry; 1988 Aug; 45(8):718-26. PubMed ID: 2840050
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
McDougle CJ; Krystal JH; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1995 Mar; 118(2):127-35. PubMed ID: 7617798
[TBL] [Abstract][Full Text] [Related]
4. Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR; Breier A
Arch Gen Psychiatry; 1984 Aug; 41(8):751-63. PubMed ID: 6742977
[TBL] [Abstract][Full Text] [Related]
5. Neurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.
Charney DS; Woods SW; Goodman WK; Heninger GR
Am J Psychiatry; 1987 Aug; 144(8):1030-6. PubMed ID: 3037926
[TBL] [Abstract][Full Text] [Related]
6. Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.
Charney DS; Heninger GR; Redmond DE
Life Sci; 1983 Jul; 33(1):19-29. PubMed ID: 6865647
[TBL] [Abstract][Full Text] [Related]
7. Alpha-2 adrenergic receptor sensitivity and the mechanism of action of antidepressant therapy. The effect of long-term amitriptyline treatment.
Charney DS; Heninger GR; Sternberg DE
Br J Psychiatry; 1983 Mar; 142():265-75. PubMed ID: 6305451
[TBL] [Abstract][Full Text] [Related]
8. Alpha 2-adrenergic receptor function in depression. The cortisol response to yohimbine.
Price LH; Charney DS; Rubin AL; Heninger GR
Arch Gen Psychiatry; 1986 Sep; 43(9):849-58. PubMed ID: 3019271
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibitory noradrenergic responses to clonidine in 25 depressed patients and 25 normal control subjects.
Siever LJ; Uhde TW; Jimerson DC; Lake CR; Silberman ER; Post RM; Murphy DL
Am J Psychiatry; 1984 Jun; 141(6):733-41. PubMed ID: 6329004
[TBL] [Abstract][Full Text] [Related]
10. Noradrenergic function in generalized anxiety disorder: effects of yohimbine in healthy subjects and patients with generalized anxiety disorder.
Charney DS; Woods SW; Heninger GR
Psychiatry Res; 1989 Feb; 27(2):173-82. PubMed ID: 2540501
[TBL] [Abstract][Full Text] [Related]
11. Noradrenergic function and the mechanism of action of antianxiety treatment. II. The effect of long-term imipramine treatment.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1985 May; 42(5):473-81. PubMed ID: 2985014
[TBL] [Abstract][Full Text] [Related]
12. Abnormal regulation of noradrenergic function in panic disorders. Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1986 Nov; 43(11):1042-54. PubMed ID: 3021083
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment.
Charney DS; Heninger GR; Sternberg DE; Redmond DE; Leckman JF; Maas JW; Roth RH
Arch Gen Psychiatry; 1981 Dec; 38(12):1334-40. PubMed ID: 6274268
[TBL] [Abstract][Full Text] [Related]
14. Noradrenergic function and the mechanism of action of antianxiety treatment. I. The effect of long-term alprazolam treatment.
Charney DS; Heninger GR
Arch Gen Psychiatry; 1985 May; 42(5):458-67. PubMed ID: 2859008
[TBL] [Abstract][Full Text] [Related]
15. Behavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbine.
Charney DS; Breier A; Jatlow PI; Heninger GR
Psychopharmacology (Berl); 1986; 88(2):133-40. PubMed ID: 3081923
[TBL] [Abstract][Full Text] [Related]
16. Effects of desipramine and yohimbine on alpha 2- and beta-adrenoreceptor sensitivity.
Johnson RW; Reisine T; Spotnitz S; Wiech N; Ursillo R; Yamamura HI
Eur J Pharmacol; 1980 Oct; 67(1):123-7. PubMed ID: 6252022
[TBL] [Abstract][Full Text] [Related]
17. Noradrenergic neuronal dysregulation in panic disorder: the effects of intravenous yohimbine and clonidine in panic disorder patients.
Charney DS; Woods SW; Krystal JH; Nagy LM; Heninger GR
Acta Psychiatr Scand; 1992 Oct; 86(4):273-82. PubMed ID: 1333719
[TBL] [Abstract][Full Text] [Related]
18. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients.
Stine SM; Southwick SM; Petrakis IL; Kosten TR; Charney DS; Krystal JH
Biol Psychiatry; 2002 Apr; 51(8):642-51. PubMed ID: 11955464
[TBL] [Abstract][Full Text] [Related]
19. Alpha-adrenergic receptor subtypes.
Hoffman BB; Lefkowitz RJ
N Engl J Med; 1980 Jun; 302(25):1390-6. PubMed ID: 6246426
[No Abstract] [Full Text] [Related]
20. New studies and perspectives on the noradrenergic receptor system in depression: effects of the alpha 2-adrenergic agonist clonidine.
Siever LJ; Uhde TW
Biol Psychiatry; 1984 Feb; 19(2):131-56. PubMed ID: 6324896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
